Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04528459 · ClinicalTrials.gov registry record · NA
Computer-Assisted Fixation of Trochanteric Femur Fractures
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04528459 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 12 participants.
The verdict
NCT04528459, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether the Stryker© ADAPT™ augmented-reality platform can assist surgeons in optimizing placement of the lag screw component of the Stryker© Gamma™ cephalomedullary nail.
Interventions
- DEVICE Stryker© ADAPT™ platform
- RADIATION Traditional fluoroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2021-06-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04528459
The ClinicalTrials.gov registry entry for NCT04528459 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stryker© ADAPT™ platform is the first listed.
NCT04528459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04528459 about?
NCT04528459 is a clinical study titled "Computer-Assisted Fixation of Trochanteric Femur Fractures". The purpose of this study is to assess whether the Stryker© ADAPT™ augmented-reality platform can assist surgeons in optimizing placement of the lag screw component of the Stryker© Gamma™ cephalomedullary nail.
What is the current status of trial NCT04528459?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2021-01-01. Estimated completion is 2021-06-18.
What interventions are being tested in trial NCT04528459?
The interventions under investigation include: Stryker© ADAPT™ platform (DEVICE), Traditional fluoroscopy (RADIATION).
Who is sponsoring clinical trial NCT04528459?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.